Recent Patents on Biotechnology
Title:Patent Selections
Volume: 12 Issue: 1
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Patent Selections, Recent Patents on Biotechnology 2018; 12 (1) . https://dx.doi.org/10.2174/187220831201171222115657
DOI https://dx.doi.org/10.2174/187220831201171222115657 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gene Therapy for Haemophagocytic Lymphohistiocytosis
Current Gene Therapy Approaches for Developing Novel Microtubule Targeting Agents (MTAs) for Therapeutic Exploitation
Current Pharmaceutical Design Preparation of Cationic Lipid-coated Ultrasound Contrast Agents and Noninvasive Gene Transfection Via Ultrasound-targeted Microbubble Destruction
Current Pharmaceutical Design Gemini Surfactant Based Carriers in Gene and Drug Delivery
Current Medicinal Chemistry Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Current Medicinal Chemistry Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine
Current Radiopharmaceuticals Human-Derived Organ-on-a-Chip for Personalized Drug Development
Current Pharmaceutical Design Topical Dermatological Drug Delivery: Quo Vadis?
Current Drug Delivery In Vitro Antioxidant Activity of Some Novel Synthetic Mononuclear Ruthenium (II) Compounds
Letters in Drug Design & Discovery Microcirculation in Sepsis: New Perspectives
Current Vascular Pharmacology The NK-1 Receptor: A New Target in Cancer Therapy
Current Drug Targets Editorial (Hot Topic: Translational Implications of Natural Agents)
Current Drug Targets ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy The Glutathione System as an Attractive Therapeutic Target
Drug Design Reviews - Online (Discontinued) Stem Cell Transplantation in Multiple Myeloma
Current Cancer Drug Targets Rock1 & 2 Perform Overlapping and Unique Roles in Angiogenesis and Angiosarcoma Tumor Progression
Current Molecular Medicine Population Pharmacogenomics and Personalized Medicine Research in Hungary: Achievements and Lessons Learned
Current Pharmacogenomics and Personalized Medicine Synthesis of Nitroaromatic Compounds as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry